David Francischelli Email & Phone Number

Minneapolis, Minnesota, US

• Start-up stage venture developing a direct-to-consumer, wearable, wireless, non-invasive device for transcranial neuromodulation. Applying Western technology to Eastern practices of yoga, meditation and mindfulness to.
• Established university relationships to design and build functional hardware, software and mobile app prototypes.
• Partnered with MN Technology Association to target NIH-SBIR funding.
• Created pitch deck and presented to accelerators and VCs to secure financial backing.
• Expanded FDA indications for publicly-traded client company's existing product line by identifying appropriate in vitro testing.
• Testified as expert witness in lawsuit involving medical device company and contract developer/manufacturer.CONSULTING SERVICES:

Maple Grove, Minnesota, US

• Francis Medical is a venture-backed, clinical stage medical device company committed to developing urological cancer treatments that are safer and more effective than current standards of care.Executive Leadership Team.
• Supported multi-center US clinical trial to demonstrate safety and efficacy of cancer therapy by vapor ablation.
• Identified external hardware and software strategic partners and established relationships to develop Vanquish - an image-guided system and procedure to treat prostate cancer.
• Through testing and collaboration with KOLs, identified features and requirements for next generation systems and created product roadmap to guide company’s go-to-market strategy.
• Secured $65M in financing from strategic partners and venture capital investors.

Mason, Ohio, US

• AtriCure is a publicly-traded (NASDAQ: ATRC) medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation (AF), exclusion of the left atrial appendage and Cryo Nerve.
• Developed a product roadmap and established a cadence of annually launching multiple new, innovative systems (disposable, implantable, software and capital), which is the foundation to a 5-year CAGR of greater than 20%.
• Grew R&D function from a team of 20, to over 60 within 3 years. Resulted in a shift in the corporate innovation culture and a greater than 30-point increase in Vitality Index.
• Established a Research & Technology division to evaluate new and innovative whitespace technologies and market opportunities that dovetail with current product offerings. Resulted in a 5x increase in issued patents and.
• Conducted due diligence and integration of two acquisitions, valued at over $175M, within two years.
• Established a cross functional governing board to review and provide guidance and oversight to New Product Development teams while improving communication with executive team.

Minneapolis, MN, US

• Medtronic - Structural Heart DivisionProgressively responsible positions, ultimately directing all aspects of research and development for cardiac radiofrequency, cryogenic and PFA ablation technologies, including.
• Developed multiple generations of the Cardioblate irrigated ablation system to continuously improve customer acceptance and patient outcomes. This family of products generates over $60 million in annual revenue.
• Board Member of cross-functional management team focused on developing and executing a strategy to position the company as a leader in the fields of ablation and arrhythmia management.
• Conducted due diligence assessment prior to ATS Medical acquisition and successfully integrated CryoMaze R&D ahead of plan.
• Core Team Leader of a 13-member Six-Sigma initiative to establish a lean product development process and improve R&D efficiency. Estimated 25% savings in project cycle time and cost.
• Developed an endoscopic procedure and suite of instruments, including the Cardioblate Closure Atrial Appendage Isolation System, to reduce the incidence of stroke.

Minneapolis, MN, US

• Medtronic - Atrial Fibrillation DivisionConducted foundational research & clinical trials, developed business plan and sourced manufacturing & distribution for an innovative ablation platform.
• Created new technologies business with revenue of $650+ million.
• Championed the design, development and evaluation of disposable surgical and catheter-based tools for the management of atrial fibrillation using RF ablation technology.
• Initiated and coordinated cross-divisional efforts to define, develop and test innovative ablation catheters for company’s early entrance into the AF Market.
• Collaborated with Key Opinion Leaders to define and execute a strategy for developing radio frequency ablation as standard of care for atrial fibrillation.

Minneapolis, MN, US

• Medtronic - Ventures DivisionProgressively responsible positions within the Cardiac Assist Venture, leveraging neuromodulation approaches to develop therapies for heart failure and cardiac arrhythmias. Ultimately.
• Managed research initiatives with external consultants and institutions to ensure that $1 million in annual research funding was applied to fulfill divisional objectives and that defined milestones were met.
• Facilitate transfer of research projects and technology to Product Development, including the development of Transform, an implantable Cardiomyostimulator/Defibrillator. Promoted an environment of information sharing.
• Designed, managed and conducted in-vitro, in-vivo GLP and IDE clinical evaluations of VADs, blood pumps and implantable pulse generators for FDA and CE mark submissions and subsequent market release.
• Collaborated closely with cardiac surgeons to develop tools and techniques for minimally invasive cardiomyoplasty and aortomyoplasty procedures.
• Recognized as Medtronic’s Technical Contributor of the Year for 1996.

Worcester, MA, US

• Provided technical leadership in projects involving the design, modification and installation of medical instrumentation.
• Directed biomedical/clinical engineering activities such as pre-purchase evaluations, bid specifications, maintenance and repair of medical equipment, risk management and staff training.
• Specified and installed remote patient monitoring system on cardiac step-down floors.

Mba, New Venture Management / Entrepreneurship

Executive Development Program

Ms, Bioengineering

Ba, Biology